E-LIB Suche - Ergebnisse für: Blauvelt, A

1

Optimizing maintenance therapy in responders to abrocitinib..:

Thyssen, J. P. ; Silverberg, J. I. ; Ruano, J....
Journal of the European Academy of Dermatology and Venereology. , 2024

Link: https://doi.org/10.1111/..

2

P1081 Pharmacokinetics and immunogenicity of the ustekinuma..:

Chow, V ; Mytych, D T ; Blauvelt, A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1943-i1943 , 2024

Link: https://doi.org/10.1093/..

3

CO230 Efficacy and Safety of Roflumilast Foam 0.3% in Patie..:

Blauvelt, A. ; Draelos, Z.D. ; Gooderham, M....
Value in Health. 26 (2023) 6 - p. S59 , 2023

Link: https://doi.org/10.1016/..

4

ONCE-DAILY ROFLUMILAST CREAM 0.15% FOR ATOPIC DERMATITIS: P..:

Eichenfield, L. ; Boguniewicz, M. ; Simpson, E....
Annals of Allergy, Asthma & Immunology. 131 (2023) 5 - p. S91 , 2023

Link: https://doi.org/10.1016/..

5

RUXOLITINIB CREAM DEMONSTRATES DURABLE LONG-TERM DISEASE CO..:

Geng, B. ; Eichenfield, L. ; Kircik, L....
Annals of Allergy, Asthma & Immunology. 131 (2023) 5 - p. S13 , 2023

Link: https://doi.org/10.1016/..

6

LONG-TERM SAFETY IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC D..:

Blauvelt, A. ; Eichenfield, L. ; Sierka, D....
Annals of Allergy, Asthma & Immunology. 129 (2022) 5 - p. S19 , 2022

Link: https://doi.org/10.1016/..

7

MEANINGFUL RESPONSES IN TRALOKINUMAB-TREATED ADOLESCENTS WI..:

Paller, A. ; Blauvelt, A. ; Soong, W....
Annals of Allergy, Asthma & Immunology. 129 (2022) 5 - p. S74 , 2022

Link: https://doi.org/10.1016/..

8

Dupilumab provides long-term efficacy for up to 4 years in ..:

Blauvelt, A. ; Thyssen, J.P. ; Lockshin, B....
Revue Française d'Allergologie. 62 (2022) 3 - p. 321 , 2022

Link: https://doi.org/10.1016/..

9

Super‐response to guselkumab treatment in patients with mod..:

Reich, K. ; Gordon, K.B. ; Strober, B....
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 12 - p. 2393-2400 , 2022

Link: https://doi.org/10.1111/..

10

Three‐year efficacy and safety of certolizumab pegol for th..:

Warren, R. B. ; Lebwohl, M. ; Sofen, H....
Journal of the European Academy of Dermatology and Venereology. 35 (2021) 12 - p. 2398-2408 , 2021

Link: https://doi.org/10.1111/..

11

Long‐term safety of risankizumab from 17 clinical trials in..:

Gordon, K.B. ; Lebwohl, M. ; Papp, K.A....
British Journal of Dermatology. 186 (2021) 3 - p. 466-475 , 2021

Link: https://doi.org/10.1111/..

12

PBI17 Comparison of Switching Patterns Among Patients with ..:

Blauvelt, A. ; Shi, N. ; Somani, N....
Value in Health. 24 (2021) - p. S17-S18 , 2021

Link: https://doi.org/10.1016/..

13

Decreased quality of life in people with psoriasis and psor..:

Gondo, G.C. ; Merola, J.F. ; Bell, S.J..
British Journal of Dermatology. 185 (2021) 6 - p. 1264-1265 , 2021

Link: https://doi.org/10.1111/..

14

An integrated safety analysis of treatment‐emergent fungal ..:

Blauvelt, A. ; Ramharter, M. ; Cohen, A.D....
Journal of the European Academy of Dermatology and Venereology. 35 (2021) 11 - p. , 2021

Link: https://doi.org/10.1111/..

15

Concerns and perceptions of patients with psoriatic disease..:

Gondo, G.C. ; Bell, S.J. ; Slayden, J...
Journal of the European Academy of Dermatology and Venereology. 35 (2021) 6 - p. , 2021

Link: https://doi.org/10.1111/..